During the most recent 90-day period, previous to the date of this filing, there has been one additional insider transaction which has resulted in the acquisition of 200,000 of company shares. Relative to the preceding 90-day window of time, there were 35 transactions from 7 insiders that resulted in the net acquisition of 4,405,250 shares.
This is lower than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 39.7 transactions per company, and disposition of 6,418 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119054580/xslF345X03/doc4.xml
|2020, and 2021 Estimates for Zynex Decreased but Q2 ...|
|2020 and 2021 Estimates for Zions Bancorporation Sca...|
|Joyy Inc's 2021 Earnings Forecast Raised|
|2020, 2021 Earnings Estimates for Cimarex Energy Raised|
|Analysts' Increase Weyerhaeuser's Q2, 2020, 2021 Ear...|